trans,trans-1,5-Bis(4-methoxyphenyl)-1,4-pentadien-3-one>98.0%(GC)200mg

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

N-(Furan-2-ylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 1g

6-Iodoimidazo[1,2-a]pyridine hydrochloride, 97.0%, 10g

2-((3-carboxypropyl)carbamoyl)benzoic acid, 95.0%, 1g

2-Pyridin-3-yl-1H-quinazolin-4-one, 97%, 250mg

2-Nitro-4,6-bis(trifluoromethyl)aniline, 95.0%, 25g

(S)-1-Cyclopropylethanamine hydrochloride, 95.0%, 250mg

3-(5-Methyl-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-propionic acid, 95.0%, 2.5g

3-(2,3-Dichlorophenyl)pyrrolidine hydrochloride, 95.0%, 100mg

4-CHLORO-2-(TRIFLUOROMETHOXY)BENZOIC ACID, 95.0%, 25g

1-(4-BROMO-3,5-DIMETHYLPHENYL)-5,5-DIMETHYLIMIDAZOLIDINE-2,4-DIONE, 95%, 250mg

Buffer solution pH 3.776 ±0.012 (25°C), ROTI®Calipure ready to use, 1 l, plastic packaging.